Ubs Group Ag Biogen Inc. Put Options Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $2.65 Million - $3.29 Million	-13,900 Reduced 8.04%	158,900 $36.8 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $18.4 Million - $23.2 Million	-86,700 Reduced 33.41%	172,800 $37.3 Million
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $1.42 Million - $1.71 Million	-6,400 Reduced 2.41%	259,500 $67.2 Million
Q3 2023 Nov 09, 2023	BUY	$253.3 - $285.89 $30.1 Million - $33.9 Million	118,700 Added 80.64%	265,900 $68.3 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $3.08 Million - $3.56 Million	11,200 Added 8.24%	147,200 $41.9 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $7.88 Million - $8.97 Million	-30,700 Reduced 18.42%	136,000 $37.8 Million
Q4 2022 Feb 08, 2023	BUY	$252.44 - $306.72 $3.56 Million - $4.32 Million	14,100 Added 9.24%	166,700 $46.2 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $3.41 Million - $4.7 Million	17,500 Added 12.95%	152,600 $40.7 Million
Q2 2022 Aug 10, 2022	BUY	$187.54 - $223.02 $3.3 Million - $3.93 Million	17,600 Added 14.98%	135,100 $27.6 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $26.7 Million - $33.7 Million	-138,000 Reduced 54.01%	117,500 $24.7 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $2.92 Million - $3.75 Million	13,034 Added 5.38%	255,500 $61.3 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $7.61 Million - $9.93 Million	-26,900 Reduced 9.99%	242,466 $68.6 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $13.2 Million - $21.2 Million	51,000 Added 23.36%	269,366 $93.3 Million
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $8.84 Million - $10.4 Million	36,366 Added 19.98%	218,366 $61.1 Million
Q4 2020 Feb 11, 2021	BUY	$236.26 - $355.63 $6.31 Million - $9.5 Million	26,700 Added 17.19%	182,000 $44.6 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $18.5 Million - $21.4 Million	-70,000 Reduced 31.07%	155,300 $44.1 Million
Q2 2020 Jul 31, 2020	BUY	$258.66 - $342.55 $517,320 - $685,100	2,000 Added 0.9%	225,300 $60.3 Million
Q1 2020 May 01, 2020	BUY	$268.85 - $341.04 $21.2 Million - $26.9 Million	78,900 Added 54.64%	223,300 $70.6 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $1.36 Million - $1.89 Million	-6,200 Reduced 4.12%	144,400 $42.8 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $10.9 Million - $12.2 Million	50,000 Added 49.7%	150,600 $35.1 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $4.61 Million - $5.08 Million	-21,000 Reduced 17.27%	100,600 $23.5 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $16.7 Million - $26.1 Million	77,100 Added 173.26%	121,600 $28.7 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $5.43 Million - $6.88 Million	19,500 Added 78.0%	44,500 $13.4 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $2.58 Million - $3.07 Million	10,000 Added 66.67%	25,000 $7.26 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $1.3 Million - $1.84 Million	-5,000 Reduced 25.0%	15,000 $4.11 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $276,876 - $310,122	-900 Reduced 4.31%	20,000 $6.37 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $4.51 Million - $5.28 Million	16,030 Added 329.16%	20,900 $6.54 Million
Q2 2017 Aug 14, 2017	BUY	N/A	670 Added 15.95%	4,870 $1.32 Million
Q1 2017 Nov 14, 2017	BUY	N/A	4,200	4,200 $1.15 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account